Latest Commercialization News

PYC Therapeutics announces the resignation of CEO Dr Rohan Hockings, appointing Chairman Alan Tribe as interim Managing Director while searching for a permanent replacement.

OD6 Metals has launched a metallurgical diamond core drilling program at its Splinter Rock Rare Earth Project, aiming to refine heap leach processing and produce high-quality rare earth samples for offtake talks.

MyEco Group has appointed Marie de Perthuis as its new CEO, aiming to leverage her extensive FMCG and retail experience to drive sales growth and build on recent operational restructuring.

Global Laser Enrichment, Silex’s exclusive licensee, has completed large-scale uranium enrichment testing, advancing the SILEX technology closer to commercial deployment in the US nuclear fuel market.

Advanced Health Intelligence has appointed Dylan Garnett as its new CEO, signaling a strategic pivot towards commercialisation and revenue growth. Garnett’s extensive background in healthcare, insurance, and digital health positions AHI for its next growth phase.

Cobalt Blue Holdings has secured a crucial works approval for its Kwinana Cobalt Refinery, pushing Australia’s first dedicated cobalt processing plant closer to a final investment decision by the end of 2025.

Codeifai Limited has mutually terminated its acquisition of Trust Codes, redirecting focus to its upcoming QuantumAI Secure platform acquisition and SaaS expansion.

VBX Limited reports promising low-silica bauxite discoveries at East Kalumburu A near its flagship Wuudagu project, alongside key strategic appointments and ongoing drilling programs advancing the project towards a targeted DFS completion in early 2026.

Xstate Resources has completed well pad construction for its Diona-1 well in Queensland’s Surat-Bowen Basin and is poised to begin drilling with a 51% interest in ATP 2077.

Orthocell’s nerve repair device Remplir is being adopted in Australia for nerve-sparing prostate cancer surgeries, aiming to reduce erectile dysfunction and urinary incontinence post-operation. This development could significantly expand Remplir’s market reach globally.

Medallion Metals has taken a crucial step forward by ordering a secondary ball mill to upgrade the Cosmic Boy Concentrator, underpinning its Sulphide Production Strategy and advancing its feasibility study toward a final investment decision.

Race Oncology has uncovered that its anticancer drug bisantrene exists as three light-sensitive isomers, with only one showing potent activity. The company has filed patents to protect this active form, potentially extending its intellectual property rights until 2045.